Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Tilray Inc

Start price
Target price
Perf. (%)
€1.79
12.05.24
-
12.05.25
-4.97%
24.05.24

Risky Investment
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€205.20
12.05.24
€207.00
12.05.25
3.85%
06.06.24

Good rating
Standard Investments for future growth
Innovative
Differentiated customer and product portfolio
buy
Vonovia SE

Start price
Target price
Perf. (%)
€27.72
12.05.24
€28.00
12.05.25
7.22%
18.05.24

Could be worthwhile Investment >10% per year
Higher EBIT margin than peer group
Fair valuation
High dividend yield expected
buy
Vistra Energy

Start price
Target price
Perf. (%)
€87.82
12.05.24
€90.00
12.05.25
10.38%
28.05.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Cliq Digital AG

Start price
Target price
Perf. (%)
€8.88
12.05.24
€11.00
12.05.25
-10.59%
06.07.24

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
buy
Plastic Omnium S.A.

Start price
Target price
Perf. (%)
€11.60
11.05.24
-
11.05.25
-6.38%
25.05.24

Could be worthwhile Investment >10% per year
buy
High Co

Start price
Target price
Perf. (%)
€3.13
11.05.24
-
11.05.25
-3.51%
25.05.24

Could be worthwhile Investment >10% per year
buy
Armata Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€2.82
11.05.24
€4.00
11.05.25
-17.02%
19.05.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€8.70
11.05.24
€82.00
11.05.25
39.26%
19.05.24

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
Low dividend yield expected
buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€4.37
10.05.24
-
10.05.25
-27.99%
12.05.24

Risky Investment
buy
Münchener Rückversicherungs-Gesellschaft AG

Start price
Target price
Perf. (%)
€453.20
10.05.24
€460.00
10.05.25
3.13%
27.06.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
High dividend yield expected
buy
Mercedes-Benz Group AG

Start price
Target price
Perf. (%)
€68.13
10.05.24
€79.00
10.05.25
-0.54%
13.05.24

Could be worthwhile Investment >10% per year
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.96
10.05.24
-
10.05.25
4.80%
11.05.24

Could be worthwhile Investment >10% per year
buy
Virgin Galactic Holdings Inc.

Start price
Target price
Perf. (%)
€0.93
10.05.24
-
04.04.25
-30.95%
17.06.24

Growths much faster than the competition
Could be very worthwhile Investment >20% year
Sustainability is very important
Revenue growth > 30% per year expected
buy
Metasphere Labs Inc.

Start price
Target price
Perf. (%)
€1.60
09.05.24
-
09.06.24
10.03%
10.06.24

Could be very worthwhile Investment >20% year
Teva Pharmaceutical Industries Ltd ADR

Start price
Target price
Perf. (%)
€14.70
09.05.24
-
09.05.25
4.76%
24.06.24

Top 10 in its market
Future proof or reliable business model
buy
Unipol Gruppo Finanziario SpA

Start price
Target price
Perf. (%)
€8.56
08.05.24
-
22.05.24
6.89%
22.05.24

Virgin Galactic Holdings Inc.

Start price
Target price
Perf. (%)
€0.93
08.05.24
-
04.04.25
-0.41%
10.05.24

Growths much faster than the competition
Could be very worthwhile Investment >20% year
Sustainability is very important
Revenue growth > 30% per year expected
Peloton Interactive Inc.

Start price
Target price
Perf. (%)
€3.76
07.05.24
€5.00
11.03.25
7.19%
13.05.24

High valuation
Low dividend yield expected
negative Cash Flow expected
Bad rating
buy
Virgin Galactic Holdings Inc.

Start price
Target price
Perf. (%)
€0.99
07.05.24
-
04.04.25
-5.67%
08.05.24

Growths much faster than the competition
Could be very worthwhile Investment >20% year
Sustainability is very important
Revenue growth > 30% per year expected
buy
T.Rowe Price Group Inc.

Start price
Target price
Perf. (%)
€103.50
07.05.24
-
07.05.25
-0.33%
11.05.24

Tc Biopharm (holdings) Plc

Start price
Target price
Perf. (%)
€2.14
06.05.24
-
06.05.25
-37.38%
06.05.24

Risky Investment
buy
Amgen Inc.

Start price
Target price
Perf. (%)
€287.40
06.05.24
€295.00
06.05.25
1.79%
28.06.24

Could be worthwhile Investment >10% per year
High dividend yield expected
positive Cash Flow expected
Good rating
buy
Varta AG

Start price
Target price
Perf. (%)
€10.25
04.05.24
-
04.06.24
-3.61%
05.06.24

buy
Arca Biopharma

Start price
Target price
Perf. (%)
€2.98
03.05.24
€6.00
03.05.25
4.70%
13.05.24

Could be very worthwhile Investment >20% year